IBIO INC (IBIO)
US4510337086 - Common Stock
3 Healthcare Stocks Short Sellers Are Prescribing for Trouble
The healthcare industry is one of the most potent yet also one of the most competitive. This has short sellers out for blood.
These stocks are moving in today's session
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
Which stocks are gapping on Monday?
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Canada Goose Layoffs 2024: What to Know About the Latest GOOS Job Cuts
Canada Goose layoffs are in the news Wednesday as the luxury apparel company prepares to cut 17% of its corporate employees.
RENT Stock Alert: Rent the Runway Preps for a 1-for-20 Reverse Stock Split
Rent the Runway stock is falling on Wednesday after the company announced a one-for-20 reverse split for its shares coming in April.
Why Is iBio (IBIO) Stock Up 125% Today?
IBIO stock is soaring after the firm announced that it would launch a partnership based on AI and obesity treatments.
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
– Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments – – iBio to use its patented generative...
iBio Announces $15.0 Million Private Placement
– Purchase price of $2.85 represents a premium of 148+% to last close –
iBio stock jumps on sale of preclinical PD-1 agonist antibody program (NYSE:IBIO)
iBio shares surge as the biopharmaceutical company announces the sale of its preclinical PD-1 agonist antibody program to Otsuka Pharmaceutical, securing...
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka
– Deal includes $1 million upfront and potential future milestone payments – – iBio’s proprietary therapeutic pipeline will now be comprised entirely of...
iBio Announces Participation in 23rd Annual PepTalk Conference
- VP of Platform Technologies, Matt Greving, to give podium presentation on enhancing bispecific T-cell engager discovery and development with machine...
iBio to extend maturity date of credit facility (NYSE:IBIO)
iBio extends credit facility maturity date, providing more time for planned divestiture.
iBio Amends and Extends Maturity of Credit Agreement
– Extends maturity date to March 29, 2024 – – Allows for more time to complete planned divestiture of legacy CDMO business - BRYAN, Texas and SAN...
Piper Sandler Is Souring on Albemarle (ALB) Stock
Albemarle stock is falling on Tuesday alongside a downgrade and price target reduction for ALB shares from a Piper Sandler analyst.
Why Is SilverSun Technologies (SSNT) Stock Down 28% Today?
SilverSun Technologies stock is falling on Tuesday but that's only due to shares of SSNT giving up ground that was gained on Monday.
Why Is iBio (IBIO) Stock Down 41% Today?
Ibio stock is falling on Tuesday after the biotechnology company announced the pricing of its shares in a public offering.
iBio, Inc. Announces Pricing of $4.5 Million Public Offering
BRYAN, Texas and SAN DIEGO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), today announced the pricing of its...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning!
iBio to undertake reverse stock split at 20-to-1 ratio (NYSE:IBIO)
iBio Inc (IBIO) announces a 20-to-1 reverse stock split, with trading on a split-adjusted basis starting on November 29, 2023.
iBio Announces Reverse Stock Split
BRYAN, Texas and SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”) today announced that its Board of...
iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 Bispecific
- ShieldTx potentially increases safety and developability of therapeutic antibodies for difficult targets and modes of action - BRYAN, Texas and SAN...
iBio files for mixed shelf of undisclosed size (NYSE:IBIO)
iBio (NYSE:IBIO) on Friday filed a prospectus for a mixed securities shelf offering, size undisclosed.This prospectus is not an offer to sell these...
iBio Explains Recent Filing of Registration Statement
– No new securities are being registered under the Post-Effective Amendment –...
iBio Announces Filing of 2023 Annual Report on SEC Form 10-K
BRYAN, Texas and SAN DIEGO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision...
iBio Announces Amendment to Credit Agreement with Woodforest
– Extends maturity date to December 31, 2023 – – Allows time to close pending sale of CDMO facility – BRYAN, Texas and SAN DIEGO, Sept. 21, 2023 (GLOBE...
iBio Reports Triple Milestone: In Vivo Proof-of-Concept for Three Programs, a Transformative Step in Advancing its Immuno-Oncology Pre-Clinical Pipeline Towards Clinical Development
– AI-powered technology enables rapid, simultaneous progress of antibodies against challenging targets – BRYAN, Texas and SAN DIEGO, Aug. 14, 2023 ...